Yagi K, Imamura T, Tada H, Chujo D, Liu J, Shima Y, et al
Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region
The mechanisms of action of tirzepatide are multiple and need to be further investigated, but the results obtained so far suggest an effect both in improving insulin resistance and in enhancing beta cell function by restoring insulin secretion
But the full range of how patients experience these drugs in the real world is still coming into focus
In total, 15% of Americans say they have used a GLP-1 drug for weight loss at some point
Retatrutide's 24.2% is the highest weight loss figure recorded for any injectable obesity medication in a controlled trial